Quantbot Technologies LP Organogenesis Holdings Inc. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.97 - $4.21 $38,612 - $82,516	19,600 New	19,600 $80,000
Q2 2023 Aug 08, 2023	BUY	$1.9 - $4.3 $33,595 - $76,032	17,682 New	17,682 $58,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $3.43 $7,440 - $10,290	3,000 New	3,000 $8,000
Q2 2022 Aug 09, 2022	SELL	$4.74 - $8.15 $30,535 - $52,502	-6,442 Reduced 28.13%	16,458 $80,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $148,163 - $219,153	22,900 New	22,900 $174,000
Q4 2021 Feb 11, 2022	SELL	$9.02 - $13.5 $12,628 - $18,900	-1,400 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$13.71 - $17.18 $8,226 - $10,308	600 Added 75.0%	1,400 $19,000
Q2 2021 Aug 12, 2021	BUY	$14.92 - $23.23 $11,936 - $18,584	800 New	800 $13,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.